Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.

Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.

<h4>Background</h4>Intravenous thrombolysis using recombinant tissue plasminogen activator remains the mainstay treatment of acute ischemic stroke (AIS), although endovascular treatment is becoming standard of care in case of large vessel occlusions (LVO). To quantify the thrombus burden...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: István Szegedi, Rita Orbán-Kálmándi, Attila Nagy, Ferenc Sarkady, Nikolett Vasas, Máté Sik, Levente István Lánczi, Ervin Berényi, László Oláh, Alexandra Crișan, László Csiba, Zsuzsa Bagoly
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/f9f2cb92308d4b51b52d72f1094f2e0f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares